81 results
8-K
EX-99.1
KA
Kineta Inc
24 May 23
Regulation FD Disclosure
9:30am
innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets
8-K
EX-99.6
yavg3x b4ufze4g0v
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.2
i3tbgym
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
7dsb3wf
10 Nov 22
Prospectus supplement
4:21pm
425
zmdp2bhl jjg
29 Aug 22
Business combination disclosure
4:03pm
8-K
EX-99.1
gc3f2hn
29 Aug 22
Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta
4:01pm
8-K
EX-99.1
4db n7tqgg
4 Aug 22
Yumanity Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
4:51pm
425
v2bgkdk9ulx54b7
28 Jun 22
Business combination disclosure
4:03pm